Why the study?
Live attenuated viral vaccines can reveal inborn errors of immunity, and reviewing the spectrum of vaccine-associated disease can highlight protective antiviral immune elements and inform vaccination approaches.
Answers are grounded in this paper and cite their sources.
Understanding the pathomechanisms of LAV-associated disease in inborn errors of immunity can inform vaccination strategies and disease management, including for those on immunomodulators.
Live attenuated viral vaccines (LAV) have saved millions of lives globally through their capacity to elicit strong, cross-reactive and enduring adaptive immune responses. However, LAV can also act as a Trojan horse to reveal inborn errors of immunity, thereby highlighting important protective elements of the healthy antiviral immune response. In the following article, we draw out these lessons by reviewing the spectrum of LAV-associated disease reported in a variety of inborn errors of immunity. We note the contrast between adaptive disorders, which predispose to both LAV and their wild type counterparts, and defects of innate immunity in which parenterally delivered LAV behave in a particularly threatening manner. Recognition of the underlying pathomechanisms can inform our approach to disease management and vaccination in a wider group of individuals, including those receiving immunomodulators that impact the relevant pathways.
No takes yet. Share an insight, caveat, or question.
Gothe et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: